Results 141 to 150 of about 70,663 (209)

Interleukin-10 gives exhausted chimeric antigen receptor (CAR) T cells a second breath. [PDF]

Cancer Commun (Lond)
Heuser-Loy C.
europepmc   +1 more source

Chimeric Antigen Receptor (CAR) T-cell Therapy in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL): A Systematic Review. [PDF]

Cureus
Ibrahiam AT, Geddada S, Ullah N, Al-Qassab ZM, Ahmed O, Khan S.   +5 more
europepmc   +1 more source

CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases. [PDF]

Cureus
Cingireddy AR, Flores B, Wuthrich J, Cingireddy AR.   +3 more
europepmc   +1 more source

Chimeric antigen receptor (CAR)-T-cell therapy for glioblastoma: what can we learn from the early clinical trials? A systematic review. [PDF]

Neurooncol Adv
Chan JTN, Henley-Waters J, Kayhanian S.
europepmc   +1 more source

Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations. [PDF]

Cancers (Basel)
Blüm P, Kayser S.
europepmc   +1 more source

Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations. [PDF]

Front Cell Dev Biol
Guijarro-Albaladejo B, Marrero-Cepeda C, Rodríguez-Arbolí E, Sierro-Martínez B, Pérez-Simón JA, García-Guerrero E.   +5 more
europepmc   +1 more source

Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy. [PDF]

Front Immunol
Aniogo E, Kujawski M, Awuah D, Cha SE, Espinosa R, Hui S, Ghimire H, Yazaki PJ, Brown CE, Wang X, Shively JE.   +10 more
europepmc   +1 more source

The efficacy and applicability of chimeric antigen receptor (CAR) T cell-based regimens for primary bone tumors: A comprehensive review of current evidence. [PDF]

J Bone Oncol
Barzegari A, Salemi F, Kamyab A, Aratikatla A, Nejati N, Valizade M, Eltouny E, Ebrahimi A.   +7 more
europepmc   +1 more source